skip to Main Content
Phone: 301-655-1084 Email: info@glycomantra.com

GlycoMantra received a SBIR Phase 1 grant from the NIDDK (NIH)

June 03, 2020

GlycoMantra was awarded a SBIR Phase 1 grant to investigate insulin resistance in type 2 diabetes.

Back To Top